Melanocyte-keratinocyte cross-talk in vitiligo

AA Touni, RS Shivde, H Echuri, RTA Abdel-Aziz… - Frontiers in …, 2023 - frontiersin.org
Vitiligo is a common acquired pigmentary disorder that presents as progressive loss of
melanocytes from the skin. Epidermal melanocytes and keratinocytes are in close proximity …

Elevated serum level of interleukin‐15 in vitiligo patients and its correlation with disease severity but not activity

MA Atwa, SMM Ali, N Youssef… - Journal of Cosmetic …, 2021 - Wiley Online Library
Background Vitiligo is a common acquired disorder of depigmentation. Its pathogenesis
entails a T helper (Th) 1‐cytotoxic T (cT) lymphocytes mediated autoimmune melanocyte …

Contributions of NR1H3 genetic polymorphisms to susceptibility and effects of narrowband UVB phototherapy to nonsegmental vitiligo

M Xu, Q Xu, Y Liu, X Li, M Wang, W Dong, Y Song… - Scientific Reports, 2023 - nature.com
Vitiligo is the most common depigmenting disorder to which both genetic and environmental
factors contribute. The aim of the current work was to evaluate the relationship between …

Study of liver X receptor-alpha gene polymorphism (rs2279238) in a sample of Egyptian vitiligo patients

AAA Taha, NS Mohamed, ET Alsayed… - Journal of the …, 2022 - journals.lww.com
Background Vitiligo is an acquired skin disorder that results from selective destruction of skin
melanocytes. It is characterized clinically by the development of depigmented macules and …

Serum Level of Interleukin-38 in Vitiligo Patients and its Alterations After Narrowband Ultraviolet Light-B Phototherapy

SH Ahmed, NN Nazmy, AK Shahat… - Benha Journal of …, 2024 - bjas.journals.ekb.eg
Background: Vitiligo is an autoimmune condition characterized by melanocyte loss and
depigmented patches. Cytokines, especially those in the Th1 and Th17 pathways, play …